請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/30467完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 廖大修 | |
| dc.contributor.author | Yu-Hua Shih | en |
| dc.contributor.author | 石韻華 | zh_TW |
| dc.date.accessioned | 2021-06-13T02:04:33Z | - |
| dc.date.available | 2012-07-12 | |
| dc.date.copyright | 2007-07-12 | |
| dc.date.issued | 2007 | |
| dc.date.submitted | 2007-07-03 | |
| dc.identifier.citation | 楊淑娟 (2005) Noni果汁抗氧化性、ACE抑制活性和其純化物質Scopoletin及衍生物之化學結構鑑定。東海大學食品科學系碩士論文。
Abraham, P., Wilfred, G., and Cathrine (1999). Oxidative damage to the lipids and proteins pf the lungs, testis and kidney of rats during carbon tetrachloride intoxication. Clin Chim Acta. 289, 177-179. Alvares, A.P., and Mannering, G.J. (1970). Two-substrate kinetics of drug-metabolizing enzyme systems of hepatic microsomes. Mol Pharmacol. 6, 206-212. Arpornsuwan, T., and Punjanon, T. (2006). Tumor cell-selective antiproliferative effect of the extract from Morinda citrifolia fruits. Phytother Res. 20, 515-517. Austin, M.A., and Krauss, R.M. (1995). LDL density and atherosclerosis. Jama 273, 115. Barter, P.J., Brewer, H.B., Jr., Chapman, M.J., Hennekens, C.H., Rader, D.J., and Tall, A.R. (2003). Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis. Arterioscler Thromb Vasc Biol. 23, 160-167. Bartosz, G. (2006). Use of spectroscopic probes for detection of reactive oxygen species. Clin Chim Acta. 368, 53-76. Beuers, U., Spengler, U., and Pape, G.R. (1991). Hepatitis after chronic abuse of senna. Lancet 337, 372-373. Bironaite, D., and Ollinger, K. (1997). The hepatotoxicity of rhein involves impairment of mitochondrial functions. Chem Biol Interact. 103, 35-50. Bissell, D.M. (2001). Chronic liver injury, TGF-beta, and cancer. Exp Mol Med. 33, 179-190. Borras, C., Sastre, J., Garcia-Sala, D., Lloret, A., Pallardo, F.V., and Vina, J. (2003). Mitochondria from females exhibit higher antioxidant gene expression and lower oxidative damage than males. Free Radic Biol Med. 34, 546-552. Brousseau, M.E., Schaefer, E.J., Wolfe, M.L., Bloedon, L.T., Digenio, A.G., Clark, R.W., Mancuso, J.P., and Rader, D.J. (2004). Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol. N Engl J Med. 350, 1505-1515. Brown, L., Rosner, B., Willett, W.W., and Sacks, F.M. (1999). Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr. 69, 30-42. Chatterjee, A., and Bardhan, N.R. (1967). Prevention of carbon tetrachloride induced adrenal hypertrophy by the use of ascorbic acid in rats. Endokrinologie 51, 306-307. Chen, J.T., Wesley, R., Shamburek, R.D., Pucino, F., and Csako, G. (2005). Meta-analysis of natural therapies for hyperlipidemia: plant sterols and stanols versus policosanol. Pharmacotherapy 25, 171-183. Christensen, N.J., Rubin, C.E., Cheung, M.C., and Albers, J.J. (1983). Ultrastructural immunolocalization of apolipoprotein B within human jejunal absorptive cells. J Lipid Res. 24, 1229-1242. El-Samaligy, M.S., Afifi, N.N., and Mahmoud, E.A. (2006). Evaluation of hybrid liposomes-encapsulated silymarin regarding physical stability and in vivo performance. Int J Pharm. 319, 121-129. Epp, O., Ladenstein, R., and Wendel, A. (1983). The refined structure of the selenoenzyme glutathione peroxidase at 0.2-nm resolution. Eur J Biochem. 133, 51-69. Fernandez-Checa, J.C., and Kaplowitz, N. (2005). Hepatic mitochondrial glutathione: transport and role in disease and toxicity. Toxicol Appl Pharmacol. 204, 263-273. Fielden, E.M., Roberts, P.B., Bray, R.C., Lowe, D.J., Mautner, G.N., Rotilio, G., and Calabrese, L. (1974). Mechanism of action of superoxide dismutase from pulse radiolysis and electron paramagnetic resonance. Evidence that only half the active sites function in catalysis. Biochem J. 139, 49-60. Griffith, O.W. (1980). Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal Biochem. 106, 207-212. Hakkinen, P.J., Frankel, R., Morse, C.C., and Witschi, H. (1983). Effect of lung, liver, and kidney toxicants on respiratory rate in the mouse. Toxicology 26, 181-192. Halliwell, B. (2007). Dietary polyphenols: good, bad, or indifferent for your health? Cardiovasc Res. 73, 341-347. Halliwell, B., and Cross, C.E. (1994). Oxygen-derived species: their relation to human disease and environmental stress. Environ Health Perspect. 102 Suppl 10, 5-12. Hashimoto, M., Kothary, P.C., and Raper, S.E. (1999). Phenobarbital in comparison with carbon tetrachloride and phenobarbital-induced cirrhosis in rat liver regeneration. J Surg Res. 81, 164-169. Havel, R.J. (1992). Role of the liver in hyperlipidemia. Semin Liver Dis. 12, 356-363. Hirazumi, A., and Furusawa, E. (1999). An immunomodulatory polysaccharide-rich substance from the fruit juice of Morinda citrifolia (noni) with antitumour activity. Phytother Res 13, 380-387. Huang, Z.Z., Li, H., Cai, J., Kuhlenkamp, J., Kaplowitz, N., and Lu, S.C. (1998). Changes in glutathione homeostasis during liver regeneration in the rat. Hepatology 27, 147-153. Hung, M.Y., Fu, T.Y., Shih, P.H., Lee, C.P., and Yen, G.C. (2006). Du-Zhong (Eucommia ulmoides Oliv.) leaves inhibits CCl4-induced hepatic damage in rats. Food Chem Toxicol 44, 1424-1431. Huuskonen, J., Olkkonen, V.M., Jauhiainen, M., and Ehnholm, C. (2001). The impact of phospholipid transfer protein (PLTP) on HDL metabolism. Atherosclerosis 155, 269-281. Ikewaki, K., Nishiwaki, M., Sakamoto, T., Ishikawa, T., Fairwell, T., Zech, L.A., Nagano, M., Nakamura, H., Brewer, H.B., Jr., and Rader, D.J. (1995). Increased catabolic rate of low density lipoproteins in humans with cholesteryl ester transfer protein deficiency. J Clin Invest. 96, 1573-1581. Kamiya, K., Tanaka, Y., Endang, H., Umar, M., and Satake, T. (2004). Chemical constituents of Morinda citrifolia fruits inhibit copper-induced low-density lipoprotein oxidation. J Agric Food Chem. 52, 5843-5848. Kim, H.J., Odend'hal, S., and Bruckner, J.V. (1990). Effect of oral dosing vehicles on the acute hepatotoxicity of carbon tetrachloride in rats. Toxicol Appl Pharmacol. 102, 34-49. Kirkman, H.N., Galiano, S., and Gaetani, G.F. (1987). The function of catalase-bound NADPH. J Biol Chem. 262, 660-666. Knodell, R.G., Ishak, K.G., Black, W.C., Chen, T.S., Craig, R., Kaplowitz, N., Kiernan, T.W., and Wollman, J. (1981). Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1, 431-435. Law, M.R. (2000). Plant sterol and stanol margarines and health. West J Med. 173, 43-47. Liu, G., Bode, A., Ma, W.Y., Sang, S., Ho, C.T., and Dong, Z. (2001). Two novel glycosides from the fruits of Morinda citrifolia (noni) inhibit AP-1 transactivation and cell transformation in the mouse epidermal JB6 cell line. Cancer Res. 61, 5749-5756. Lyman, J.L. (1986). Blood urea nitrogen and creatinine. Emerg Med Clin North Am. 4, 223-233. Merkel, M., Eckel, R.H., and Goldberg, I.J. (2002). Lipoprotein lipase: genetics, lipid uptake, and regulation. J Lipid Res. 43, 1997-2006. Millonig, G., Stadlmann, S., and Vogel, W. (2005). Herbal hepatotoxicity: acute hepatitis caused by a Noni preparation (Morinda citrifolia). Eur J Gastroenterol Hepatol. 17, 445-447. Misra, H.P., and Fridovich, I. (1972). The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem. 247, 3170-3175. Morel, Y., and Barouki, R. (1999). Repression of gene expression by oxidative stress. Biochem J. 342 Pt 3, 481-496. Moskovitz, J., Yim, M.B., and Chock, P.B. (2002). Free radicals and disease. Arch Biochem Biophys. 397, 354-359. Mueller, B.A., Scott, M.K., Sowinski, K.M., and Prag, K.A. (2000). Noni juice (Morinda citrifolia): hidden potential for hyperkalemia? Am J Kidney Dis 35, 310-312. Nadir, A., Reddy, D., and Van Thiel, D.H. (2000). Cascara sagrada-induced intrahepatic cholestasis causing portal hypertension: case report and review of herbal hepatotoxicity. Am J Gastroenterol. 95, 3634-3637. Nistor, A., Bulla, A., Filip, D.A., and Radu, A. (1987). The hyperlipidemic hamster as a model of experimental atherosclerosis. Atherosclerosis 68, 159-173. Okamoto, H., Yonemori, F., Wakitani, K., Minowa, T., Maeda, K., and Shinkai, H. (2000). A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits. Nature 406, 203-207. Olofsson, S.O., Stillemark-Billton, P., and Asp, L. (2000). Intracellular assembly of VLDL: two major steps in separate cell compartments. Trends Cardiovasc Med. 10, 338-345. Oram, J.F., and Heinecke, J.W. (2005). ATP-binding cassette transporter A1: a cell cholesterol exporter that protects against cardiovascular disease. Physiol Rev. 85, 1343-1372. Palamanda, J.R., and Kehrer, J.P. (1993). Involvement of vitamin E and protein thiols in the inhibition of microsomal lipid peroxidation by glutathione. Lipids 28, 427-431. Park, Y., and Harris, W.S. (2003). Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance. J Lipid Res. 44, 455-463. Pawlus, A.D., Su, B.N., Keller, W.J., and Kinghorn, A.D. (2005). An anthraquinone with potent quinone reductase-inducing activity and other constituents of the fruits of Morinda citrifolia (noni). J Nat Prod. 68, 1720-1722. Pippenger, C.E., Browne, R.W., and Armstrong, D. (1998). Regulatory antioxidant enzymes. Methods Mol Biol. 108, 299-313. Pradhan, S.C., and Girish, C. (2006). Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine. Indian J Med Res. 124, 491-504. Quaglia, M.G., Bossu, E., Donati, E., Mazzanti, G., and Brandt, A. (1999). Determination of silymarine in the extract from the dried silybum marianum fruits by high performance liquid chromatography and capillary electrophoresis. J Pharm Biomed Anal. 19, 435-442. Rikans, L.E., and Hornbrook, K.R. (1997). Lipid peroxidation, antioxidant protection and aging. Biochim Biophys Acta. 1362, 116-127. Roveri, A., Maiorino, M., and Ursini, F. (1994). Enzymatic and immunological measurements of soluble and membrane-bound phospholipid-hydroperoxide glutathione peroxidase. Methods Enzymol. 233, 202-212. Ruwart, M.J., Wilkinson, K.F., Rush, B.D., Vidmar, T.J., Peters, K.M., Henley, K.S., Appelman, H.D., Kim, K.Y., Schuppan, D., and Hahn, E.G. (1989). The integrated value of serum procollagen III peptide over time predicts hepatic hydroxyproline content and stainable collagen in a model of dietary cirrhosis in the rat. Hepatology 10, 801-806. Sachan, D.S., and Dodson, W.L. (1992). Effects of L-carnitine on carbon tetrachloride-induced changes in serum and liver lipids and acylcarnitines. J Environ Pathol Toxicol Oncol 11, 125-129. Sastre, J., Siegrist, S., Bulle, F., Asensi, M., Baik, J.H., Pawlak, A., and Guellaen, G. (1996). High-level expression of functional human gamma-glutamyl transpeptidase using the baculovirus system. Biochem Mol Biol Int. 38, 801-811. Schuppan, D., Jia, J.D., Brinkhaus, B., and Hahn, E.G. (1999). Herbal products for liver diseases: a therapeutic challenge for the new millennium. Hepatology 30, 1099-1104. Sen, C.K., Atalay, M., and Hanninen, O. (1994). Exercise-induced oxidative stress: glutathione supplementation and deficiency. J Appl Physiol 77, 2177-2187. Shachter, N.S. (2001). Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism. Curr Opin Lipidol. 12, 297-304. Smith, D.R. (1998). Animal models: nutrition and lipoprotein metabolism. Curr Opin Lipidol. 9, 3-6. Stadlbauer, V., Fickert, P., Lackner, C., Schmerlaib, J., Krisper, P., Trauner, M., and Stauber, R.E. (2005). Hepatotoxicity of NONI juice: report of two cases. World J Gastroenterol 11, 4758-4760. Stillemark, P., Boren, J., Andersson, M., Larsson, T., Rustaeus, S., Karlsson, K.A., and Olofsson, S.O. (2000). The assembly and secretion of apolipoprotein B-48-containing very low density lipoproteins in McA-RH7777 cells. J Biol Chem. 275, 10506-10513. Sturgill, M.G., and Lambert, G.H. (1997). Xenobiotic-induced hepatotoxicity: mechanisms of liver injury and methods of monitoring hepatic function. Clin Chem. 43, 1512-1526. Su, B.N., Pawlus, A.D., Jung, H.A., Keller, W.J., McLaughlin, J.L., and Kinghorn, A.D. (2005). Chemical constituents of the fruits of Morinda citrifolia (Noni) and their antioxidant activity. J Nat Prod. 68, 592-595. Tanaka, M., Kogawa, K., Nishihori, Y., Kuribayashi, K., Nakamura, K., Muramatsu, H., Koike, K., Sakamaki, S., and Niitsu, Y. (1997). Suppression of intracellular Cu-Zn SOD results in enhanced motility and metastasis of Meth A sarcoma cells. Int J cancer. 73, 187-192. Ugazio, G., Koch, R.R., and Recknagel, R.O. (1973). Reversibility of liver damage in rats rendered resistant to carbon tetrachloride by prior carbon tetrachloride administration: bearing on the lipoperoxidation hypothesis. Exp Mol Pathol. 18, 281-289. Vinson, J.A., and Dabbagh, Y.A. (1998). Effect of green and black tea supplementation on lipids, lipid oxidation and fibrinogen in the hamster: mechanisms for the epidemiological benefits of tea drinking. FEBS letters 433, 44-46. Wang, M.Y., and Su, C. (2001). Cancer preventive effect of Morinda citrifolia (Noni). Ann N Y Acad Sci. 952, 161-168. Wang, M.Y., West, B.J., Jensen, C.J., Nowicki, D., Su, C., Palu, A.K., and Anderson, G. (2002). Morinda citrifolia (Noni): a literature review and recent advances in Noni research. Acta Pharmacol Sin. 23, 1127-1141. Wang, N., Lan, D., Chen, W., Matsuura, F., and Tall, A.R. (2004). ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. Proc Natl Acad Sci U S A. 101, 9774-9779. Wang, P.R., Guo, Q., Ippolito, M., Wu, M., Milot, D., Ventre, J., Doebber, T., Wright, S.D., and Chao, Y.S. (2001). High fat fed hamster, a unique animal model for treatment of diabetic dyslipidemia with peroxisome proliferator activated receptor alpha selective agonists. Eur J Pharmacol. 427, 285-293. Warren, J.V., Merrill, A.J., and Stead, E.A. (1943). The Role of the Extracellular Fluid in the Maintenance of a Normal Plasma Volume. J Clin Invest. 22, 635-641. Weber, L.W., Boll, M., and Stampfl, A. (2003). Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model. Crit Rev Toxicol. 33, 105-136. Weber, P., and Raederstorff, D. (2000). Triglyceride-lowering effect of omega-3 LC-polyunsaturated fatty acids--a review. Nutr Metab Cardiovasc Dis 10, 28-37. West, B.J., Jensen, C.J., and Westendorf, J. (2006). Noni juice is not hepatotoxic. World J Gastroenterol 12, 3616-3619. Westendorf, J., Effenberger, K., Iznaguen, H., and Basar, S. (2007). Toxicological and analytical investigations of noni (Morinda citrifolia) fruit juice. J Agric Food Chem. 55, 529-537. Wiechelman, K.J., Braun, R.D., and Fitzpatrick, J.D. (1988). Investigation of the bicinchoninic acid protein assay: identification of the groups responsible for color formation. Anal Biochem. 175, 231-237. Yuce, B., Gulberg, V., Diebold, J., and Gerbes, A.L. (2006). Hepatitis induced by Noni juice from Morinda citrifolia: a rare cause of hepatotoxicity or the tip of the iceberg? Digestion 73, 167-170. Zambon, A., Bertocco, S., Vitturi, N., Polentarutti, V., Vianello, D., and Crepaldi, G. (2003). Relevance of hepatic lipase to the metabolism of triacylglycerol-rich lipoproteins. Biochem Soc Trans. 31, 1070-1074. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/30467 | - |
| dc.description.abstract | 本研究第一部分是以諾麗果汁作為實驗材料，探討其安全性及對四氯化碳誘導之大白鼠肝損傷的修復功能。結果顯示，以17.5 ml/kg諾麗果汁餵食Wistar鼠2週，對其肝腎功能皆無不良影響。且在此劑量下，能夠顯著增加大白鼠肝臟中麩胱甘肽總量 (total glutathione) 及還原態麩胱甘肽 (reduced glutathione) 的含量。而於8週的四氯化碳誘導肝損傷實驗中，Wistar鼠隨機分為六組，分別為正常組、CCl4 (0.5 ml/隻) 組、CCl4+silymarin (200mg/kg) 組、CCl4＋0.175 ml/kg諾麗果汁組、CCl4＋1.75 ml/kg諾麗果汁組及CCl4＋17.5 ml/kg諾麗果汁組，每天給予試驗品及每週一、四給予四氯化碳誘導其肝損傷。於第2週時，諾麗果汁三組尚具護肝能力，其AST、ALT活性顯著低於CCl4組。但於犧牲當週時，僅剩CCl4＋17.5 ml/kg諾麗果汁組之AST活性顯著低於CCl4組。而在肝臟抗氧化酵素SOD (superoxide dismutase)、catalase及GPx (glutathione peroxidase) 活性方面，CCl4組之活性皆顯著低於正常組。而諾麗果汁三組之SOD活性，則與正常組無顯著差異。至於肝臟中抗氧化物質方面，諾麗果汁三組之氧化態麩胱甘肽(oxidized glutathione, GSSG) 含量皆顯著低於CCl4組。且CCl4＋1.75 ml/kg諾麗果汁組及CCl4＋17.5 ml/kg諾麗果汁組之氧化壓力指標GSH/GSSG比值皆顯著高於CCl4組。由肝臟病理切片結果發現，CCl4＋0.175 ml/kg諾麗果汁組及CCl4＋17.5 ml/kg諾麗果汁組其肝細胞壞死程度顯著較CCl4組輕微。以上結果顯示，諾麗果汁可提升CCl4誘導之肝損傷大鼠之肝臟抗氧化能力及減少肝細胞之壞死。
本研究第二部分是以諾麗果汁冷凍乾燥粉末作為實驗材料，探討其對於高糖高脂誘導之倉鼠脂質代謝異常的影響。將十五隻倉鼠分為五組，分別為正常飲食組、高脂飲食 (High fat diet, HFD) 組、HFD+0.25%Noni組、HFD+0.5%Noni組及HFD+1%Noni組。7週的高糖高脂飲食確實使倉鼠之肝臟組織及腹部內臟脂肪組織重量較正常飲食組別顯著增加。而其血中三酸甘油酯及膽固醇含量亦較正常飲食組顯著上升。而同時攝食諾麗果汁冷凍乾燥粉末之高脂飲食組別，與高脂飲食組間並無顯著差異。由結果推測，諾麗果汁對於改善在高糖高脂飲食下所造成的血中三酸甘油酯及膽固醇上升，似乎沒有效果。但攝食諾麗果汁冷凍乾燥粉末之高脂飲食組別，其肝腎功能指數與正常飲食組間無顯著差異。推測此三劑量對倉鼠肝腎功能無不良影響產生。綜合以上，由本研究可知，諾麗果汁能夠藉由提升體內抗氧化能力而降低四氯化碳所引起的肝細胞壞死程度，但於降血脂方面，似乎沒有效果。 | zh_TW |
| dc.description.abstract | The aim of this study was to evaluate the safety and liver protection against carbon tetrachloride (CCl4) induced liver injury of Noni juice in rats. The results showed that 17.5 ml/kg Noni juice didn’t have adverse effects on liver and kidney in rats. The total glutathione and the reduced glutathione content in liver in rats treated with 17.5 ml/kg Noni juice were significantly increased as compared to control. In the CCl4-induced liver injury experiment, Wistar rats were administrated orally with Noni juice everyday (0.175, 1.75, and 17.5 ml/kg) and CCl4 (0.5ml/rat) twice a week for 8 weeks. CCl4 increased the AST and ALT levels in serum as compared with control group. Co-treatment with 17.5 ml/kg Noni juice decreased the AST level as compared with CCl4-treated group. CCl4 also significantly (p<0.05) decreased the activities of SOD, catalase, and GPx (glutathione peroxidase) and increased the GSSG content in liver as compared with control group. Co-treatment with Noni juice (0.175, 1.75 and 17.5 ml/kg) significantly increased the SOD activity and decreased the GSSG content as compared with CCl4-treated group. And the GSH/GSSG ratios in Noni juice-treated groups were also significantly increased as compared with CCl4- treated group. Liver histopathological results showed that Noni juice (0.175 and 17.5 ml/kg) reduced the necrotic cells induced by CCl4 in rats. The data suggest that oral administration with Noni juice for 8 weeks increased the level of antioxidants and decreased the extent of liver injury induced by CCl4 in rats.
In the other part of this experiment, the effects of freezing dried powder of Noni fruit on lipid metabolism in hamsters fed with high fat diet were evaluated. 15 hamsters were divided into 5 groups and gave them the modified diet according to PMI#5001 for 7 weeks. The high fat diet contained 15% coconut oil, 5% soy bean oil and 0.1% cholesterol. The three experimental groups contained 0.25%, 0.5% and 1% freezing dried powder of Noni fruit. It showed that HFD significantly increased the weights of liver and abdominal visceral adipose tissue as compared with control group. The levels of serum triglyceride and cholesterol were also significantly increased. Three doses of freezing dried powder of Noni fruit neither decreased the weight of liver and abdominal visceral adipose tissue nor reduced the levels of serum triglyceride and cholesterol. However, the levels of AST, ALT, BUN and creatinine showed no difference between three experimental groups and control group. It suggested that freezing dried powder of Noni fruit didn’t have adverse effects on liver and kidney in hamsters. In summary, the present study showed that Noni fruit could increase the level of antioxidants in liver and reduce the necrotic cells that were induced by CCl4 in rats. It also showed that freezing dried powder of Noni fruit didn’t have influence on hypolipidemia. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-13T02:04:33Z (GMT). No. of bitstreams: 1 ntu-96-R94442014-1.pdf: 2227470 bytes, checksum: a4f91ed9ed45530e0bd1a64c8cb0238d (MD5) Previous issue date: 2007 | en |
| dc.description.tableofcontents | 口試委員會審定書………………………………………………………………….....i
謝誌……………………………………………………………………………………ii 中文摘要…………………………………………………………………………….viii 英文摘要……………………………………………………………………………....x 第一章 序論………………………………………………………………………….1 第一節 前言…………………………………………………………………..1 第二節 諾麗之文獻整理……………………………………………………..2 第三節 自由基與抗氧化物質………………………………………………..6 第四節 四氯化碳誘導肝損傷動物模式……………………………………10 第五節 脂質代謝……………………………………………………………13 第六節 高糖高脂飲食誘導血脂異常動物模式……………………………19 第二章 研究方法與步驟.…………………………………………………………..20 第一節 四氯化碳誘導之大白鼠肝損傷實驗………………………………20 第二節 大白鼠基本數據……………………………………………………21 第三節 高糖高脂飲食誘導之倉鼠脂質代謝異常實驗…………………………29 第四節 倉鼠基本數據………………………………………………………30 第五節 統計分析……………………………………………………………31 第三章 結果………………………………………………………………………...32 第一節 諾麗果汁之安全性評估…………………………………………....32 第二節 四氯化碳誘導之大白鼠肝損傷實驗………………………………33 第三節 高糖高脂飲食誘導之倉鼠脂質代謝異常…………………………39 第四章 討論………………………………………………………………………...41 參考文獻…………………………………………………………………………… .46 | |
| dc.language.iso | zh-TW | |
| dc.title | 諾麗果之安全性及護肝與對於血脂影響之評估研究 | zh_TW |
| dc.title | Evaluations of safety, hepato-protection and effects on blood lipids of Noni fruit | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 95-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 翁祖輝,呂紹俊 | |
| dc.subject.keyword | 諾麗,安全性,護肝,四氯化碳, | zh_TW |
| dc.subject.keyword | Noni,safety,hepato-protection,carbon tetrachloride, | en |
| dc.relation.page | 82 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2007-07-04 | |
| dc.contributor.author-college | 醫學院 | zh_TW |
| dc.contributor.author-dept | 生物化學暨分子生物學研究所 | zh_TW |
| 顯示於系所單位： | 生物化學暨分子生物學科研究所 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-96-1.pdf 目前未授權公開取用 | 2.18 MB | Adobe PDF |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。